New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
11:14 EDTQCORQuestcor 'deceiving' the FDA, investors, Citron says
Citron Research in a new blog post says Questcor is "deceiving" the FDA and investors. The short-selling blog claims Questor's H.P. Acthar Gel's active ingredient is less than 20% of the label specification. Shares of Questcor are down 1% to $60.94 following Citron's report. Reference Link
News For QCOR From The Last 14 Days
Check below for free stories on QCOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for QCOR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use